Back to Search
DAVID KLONOFF, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1306882949IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G35726(CA)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
G35726(CA)
Education
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SCHOOL OF MEDICINE
Class of 1976
Research & Publications (20)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
PMID 18053320·Curr Med Res Opin·2008
3-trial
A review of continuous glucose monitoring technology.
PMID 16241880·Diabetes Technol Ther·2005
6-review
Continuous glucose monitoring: roadmap for 21st century diabetes therapy.
PMID 15855600·Diabetes Care·2005
6-review
Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
PMID 16437014·Pediatr Endocrinol Rev·2003
6-review
A flaw in the use of sulfonylurea screening to diagnose sulfonylurea overdosages.
PMID 12828830·Diabetes Technol Ther·2003
8-other
The pen is mightier than the needle (and syringe).
PMID 11911176·Diabetes Technol Ther·2001
4-observational
Serum fructosamine as a screening test for type 2 diabetes.
PMID 11469616·Diabetes Technol Ther·2000
6-review
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
PMID 18678610·Diabetes Care·2008
4-observational
Subcutaneous continuous glucose monitoring in severe burn patients.
PMID 17446759·Crit Care Med·2007
8-other
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.
PMID 17379054·Clin Ther·2007
4-observational
The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges.
PMID 14988313·Diabetes Care·2004
8-other
Technology for portable measurement of blood lactate.
PMID 14709194·Diabetes Technol Ther·2003
8-other
Microdialysis of interstitial fluid for continuous glucose measurement.
PMID 14511409·Diabetes Technol Ther·2003
8-other
The link between diabetes, military metabolic monitoring, and NASA.
PMID 12833916·Diabetes Technol Ther·2003
8-other
Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical?
PMID 12716831·Diabetes Care·2003
6-review
European trends in diabetes technology--continuous glucose measurements and computerized information-processing tools.
PMID 12614486·Diabetes Technol Ther·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1720 EL CAMINO REAL, SUITE #130
BURLINGAME, CA 94010 - Phone
- (650) 697-4345
Quick Facts
- NPI
- 1306882949
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile